Bladder Cancer Advocacy Network Responds to American Cancer Society’s 2024 Projections

Bladder Cancer Cases to Rise in Men and Women

Today, the American Cancer Society (ACS) released its annual Cancer Facts and Figures report, projecting cancer statistics for the upcoming year.  According to the ACS’s projections, in 2024, it is estimated that 83,190 individuals will receive a bladder cancer diagnosis, and 16,840 will not survive their disease.

Andrea Maddox-Smith, CEO of the Bladder Cancer Advocacy Network, (BCAN), said “While there will be more than 83,000 new cases of bladder cancer diagnosed this year, our goal remains zero estimated cases. Our commitment to advancing research and providing unwavering support to patients and families remains.”

In 2024, the total bladder cancer diagnoses are expected to rise by 1.1%, by 1.04% for men and an even larger 1.25% for women.  These projections reveal that bladder cancer continues to be one of the most common cancers in America, seventh overall and fourth among men.

To aid those grappling with bladder cancer, BCAN offers a comprehensive resource on its website. This includes a state-by-state breakdown of 2024 bladder cancer statistics, information on National Cancer Institute, National Comprehensive Cancer Network, and Veterans Administration treatment facilities, along with details on available clinical trials spanning all 50 states and the District of Columbia.

Expressing concern over the escalating number of expected bladder cancer cases, Maddox-Smith added, “Every case outlined in ACS’s 2024 report represents someone’s cherished family member or friend. As long as there is one anticipated case of bladder cancer in the United States, we will continue to work to create more and better tomorrows for patients and those who love them.”

# # #

The Bladder Cancer Advocacy Network’s (BCAN’s) mission is to increase public awareness about bladder cancer, advance bladder cancer research and provide educational and support services for the bladder cancer community.